Sargent Investment Group’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,498
Closed -$129K 194
2022
Q3
$129K Sell
1,498
-145
-9% -$12.3K 0.04% 175
2022
Q2
$130K Sell
1,643
-110
-6% -$11.9K 0.04% 175
2022
Q1
$264K Sell
1,753
-167
-9% -$24.8K 0.07% 159
2021
Q4
$325K Sell
1,920
-723
-27% -$145K 0.07% 146
2021
Q3
$612K Sell
2,643
-105
-4% -$27.4K 0.15% 103
2021
Q2
$850K Sell
2,748
-500
-15% -$156K 0.2% 78
2021
Q1
$1.13M Buy
+3,248
New +$1.1M 0.3% 65

Other funds holding CNBS

Sargent Investment Group's CNBS Position: Q4 2022 in Review

Sargent Investment Group sold out of Amplify Seymour Cannabis ETF (CNBS) in Q4 2022, closing a stake of 1,498 shares — an estimated $129K sold.

Sargent Investment Group first reported a position in CNBS in Q1 2021 and held it in 7 quarters. The position peaked at $1.13M in Q1 2021. 36 funds tracked by Wall St. Rank hold CNBS as of Q4 2022.

  • Sargent Investment Group reported no remaining Amplify Seymour Cannabis ETF position as of Q4 2022 after selling out during the quarter.
  • Sargent Investment Group sold 1,498 Amplify Seymour Cannabis ETF shares in Q4 2022, an estimated $129K.
  • Sargent Investment Group first reported a position in Amplify Seymour Cannabis ETF in Q1 2021 and held it in 7 quarters.
  • Sargent Investment Group's Amplify Seymour Cannabis ETF position peaked at $1.13M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q4 2022.

Based on Sargent Investment Group's 13F filing for Q4 2022, filed 31 Jan 2023.